|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Interest income on investments held in Trust Account | ||
| Cancellation of indebtedness | ||
| Prepaid expenses and other current assets | ||
| Change in fair value of Over-Allotment Option Liability | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Cash withdrawn from Trust Account for working capital | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from sale of Units, net of underwriting discounts paid | ||
| Payment of offering costs | ||
| Repayment of promissory note - related party IPO | ||
| Payment of insurance loan payable | ||
| Net cash provided by (used in) financing activities | ||
| Net change in cash | ||
| Cash at beginning of the period | ||
| Cash at end of the period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Prepaid expenses paid by insurance financing payable | ||
| Deferred offering costs included in accrued expenses | ||
| Deferred offering costs paid through Promissory Note - IPO Related Party | ||
| Deferred offering costs paid through prepaid expenses | ||
| Deferred underwriting fee payable |
Loading...
